REGISTERED NUMBER: 07498462 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

FOR

RICH CLINICAL SERVICES LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

R Trebilcock

E W Trebilcock

REGISTERED OFFICE:

3rd Floor

21 Perrymount Road

Haywards Heath

West Sussex

RH16 3TP

REGISTERED NUMBER:

07498462 (England and Wales)

ACCOUNTANTS:

Galloways Accounting Limited

15 West Street

Brighton

East Sussex

BN1 2RL

FIXED ASSETS

Tangible assets

4

4,485

1,198

CURRENT ASSETS

Debtors

5

1,908

12,588

Cash at bank

29,081

12,531

30,989

25,119

CREDITORS

Amounts falling due within one year

6

(7,585

)

(6,807

)

NET CURRENT ASSETS

23,404

18,312

TOTAL ASSETS LESS CURRENT LIABILITIES

27,889

19,510

PROVISIONS FOR LIABILITIES

7

(852

)

(228

)

NET ASSETS

27,037

19,282

CAPITAL AND RESERVES

Called up share capital

3

3

Retained earnings

27,034

19,279

SHAREHOLDERS' FUNDS

27,037

19,282

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 April 2025 and were signed on its behalf by:

R Trebilcock - Director

1.	STATUTORY INFORMATION

Rich Clinical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover represents revenue recognised in the accounts excluding value added tax.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Office equipment

-

25% on cost

Computer equipment

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Office

Computer

equipment

equipment

Totals

£

£

£

COST

At 1 February 2024

375

2,542

2,917

Additions

1,294

2,821

4,115

At 31 January 2025

1,669

5,363

7,032

DEPRECIATION

At 1 February 2024

375

1,344

1,719

Charge for year

82

746

828

At 31 January 2025

457

2,090

2,547

NET BOOK VALUE

At 31 January 2025

1,212

3,273

4,485

At 31 January 2024

-

1,198

1,198

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

1,908

7,326

Other debtors

-

5,262

1,908

12,588

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

1,460

6,807

Other creditors

6,125

-

7,585

6,807

7.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

852

228

Deferred

tax

£

Balance at 1 February 2024

228

Movement in year

624

Balance at 31 January 2025

852

8.	ULTIMATE CONTROLLING PARTY

During the year the company was under the control of R Trebilcock and E W Treblicock, the directors and shareholders of the company.